Viewing Study NCT02678260


Ignite Creation Date: 2025-12-25 @ 2:01 AM
Ignite Modification Date: 2025-12-30 @ 10:24 AM
Study NCT ID: NCT02678260
Status: COMPLETED
Last Update Posted: 2018-06-08
First Post: 2016-01-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study of PDR001 in Patients With Advanced Malignancies.
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module